Navigation Links
Former FDA Branch Chief of Radiation Programs Joins NDA Partners as Expert Consultant

NDA Partners Chairman Carl Peck, MD, announced today that Orhan H. Suleiman, MS, PhD, FAAPM, FHPS, former Senior Science Policy Advisor with the Center for Drug Evaluation and Research and former Branch Chief of Radiation Programs and Radiology Devices in the Center for Devices and Radiological Health, has joined the firm as an Expert Consultant.

Dr. Suleiman has expertise in health physics, medical physics, nuclear medicine, radiology, and radiation products and therapies, with 42 years of experience with state and federal governments, including 37 years at the FDA. He served as Branch Chief in CDRH, Senior Science Policy Advisor in the FDA Office of the Commissioner’s Office of Counter-terrorism, and Senior Science Policy Advisor in CDER, where he was involved in the regulatory review and approval of medical device and pharmaceutical products, safety, human subject research, and inspections. He also represented the FDA on a variety of national and international committees, including the US Nuclear Regulatory Commission’s (NRC) medical isotope committee for over 10 years. Prior to his FDA career, he served as a Health Physicist in the United States Army Environmental Hygiene Agency (USAEHA).

According to Dr. Peck, “Dr. Suleiman’s experience at FDA in CDRH and CDER, in addition to his expertise in medical physics, nuclear medicine, and radiology, will be valuable to our clients developing and seeking market approval for radiation products and therapies. We are very pleased that he has joined NDA Partners.”

Dr. Suleiman earned a doctorate in environmental health sciences (medical physics) from Johns Hopkins University and a master’s degree in zoology and radiological sciences from the University of Florida. He is an Emeritus member of the FDA’s Senior Biomedical Research Service (SBRS), Society of Nuclear Medicine and Molecular Imaging (SNMMI), Fellow of the American Association of Physicists in Medicine (AAPM), and Fellow in the Health Physics Society. He has served on numerous scientific committees, authored over 50 published articles in the scientific literature, and presented domestically and internationally on biomedical research, health physics, nuclear medicine, and molecular imaging.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Earle Martin, Chief Executive Officer
Office: 540-738-2550

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. Profil Institute Appoints Dan Bradbury, former Amylin Pharmaceutical CEO, to Board of Directors
2. DigitalPersona FingerJet Recognition Engine Top Performer in Recent MINEX Testing
3. Statement from the Secure Identity & Biometrics (SIBA) Chairman Paul Schuepp, Biometrics Expert, Former Animetrics CEO, on Providing Leadership for the Responsible Use of Biometrics in Commercial and Government Sectors
4. Chimpanzees raised as pets or performers suffer long-term effects on their behavior
5. C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer
6. Veridium Appoints Former HSBC Fintech Head James Stickland as New CEO
7. Former Anthem President Jimmy Lee Joins Fit4D’s Advisory Board
8. Barb Geiger, Former Executive Vice President of Clinical Development and Head of Global Oncology at Clinipace Inc., Joins NDA Partners as an Expert Consultant
9. Former Vice President, Biometrics at GRAIL, Inc., Tara Maddala, PhD, Joins NDA Partners as Expert Consultant
10. Former OrthoLogic Quality Assurance Director, Donna Hartzfeld, PhD, Joins NDA Partners
11. Former Vice President and Global Head of Quantitative Clinical Pharmacology at AstraZeneca Joins NDA Partners
Post Your Comments:
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a ... purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture ... facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible ...
(Date:6/28/2020)... ... , ... In an upcoming episode scheduled for the fall of 2020, Advancements ... (POCT). Check local listings for more info. , Today, the majority of testing is ... labs throughout the country. Results are then available several days later. Now, in an ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative ... to support testing operations in the fight against the COVID-19 pandemic in Zambia. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... Mass. (PRWEB) , ... July 29, 2020 , ... ... highly reliable, solid-state radar transmitter systems that can be configured to drive Klystrons, ... single controller that can drive one or two switches in a push-pull configuration; ...
(Date:7/31/2020)... MIAMI (PRWEB) , ... July 29, 2020 , ... ... nearly 200 of the top radiation centers in 16 countries, has reached its ... years, SDX® is now in routine use at top universities including University of ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new technology ... technology of its kind on the market and we were pleased that the IFT ... of traditional cultured ingredients, creating a natural way to extend the shelf life and ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
Breaking Biology Technology: